HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 20 December 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  50 papers were listed this time. Here's a few  in our areas of research interest:

Ström O, Jönsson B, Kanis JA. Intervention thresholds for denosumab in the UK using a FRAX(®)-based cost-effectiveness analysis. Osteoporos Int. 2012 Dec 7. [Epub ahead of print] PubMed PMID: 23224141.

Behl AS, Goddard KA, Flottemesch TJ, et al. Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer. J Natl Cancer Inst. 2012 Dec 5;104(23):1785-95. Epub 2012 Nov 28. PubMed PMID: 23197490; PubMed Central PMCID: PMC3514165.

Beale SJ, Bending MW, Trueman P, et al. Should we invest in environmental  interventions to encourage physical activity in England? An economic appraisal. Eur J Public Health. 2012 Dec;22(6):869-73. Epub 2012 Feb 24. PubMed PMID: 23132876.

Hettle R, Wouters H, Ayres J, et al. Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium. Respir Med. 2012 Dec;106(12):1722-33. Epub 2012 Oct 3. PubMed PMID: 23040833.